Bringing the fundamentals into focus…
Back to Royalty Pharma plc
How Royalty Pharma plc stacks up
RPRX · against 71 other Healthcare companies of similar size
Profitability
80/ 100
Below the middle of the pack.
Ranked #36 of 72 · scores higher than 49% of peers
Bars: peers in each 10-point band of the profitability score16 peers with a profitability score of 80–89, including RPRX · Click a bar to see the companies
Why profitability scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin and return on assets, which are stronger than most Healthcare peers.
- Return on invested capital is close to the peer norm. Return on invested capital: 6.7% vs peer median 4.7%
- a higher return on assets: stronger than 67% of peers. Return on assets: 4.1% vs peer median 1.7%
- a wider operating margin: stronger than 99% of peers. Operating margin: 59.6% vs peer median 7.1%
Metric by metric
Position: dot = RPRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 68 reported | 6.7% | 12.5% | 24% | 33% | |
| Operating marginHigher is better · 70 reported | 59.6% | 19.7% | 100% | 33% | |
| Return on assetsHigher is better · 69 reported | 4.1% | 7.0% | 29% | 33% | |
| Return on equityHigher is better · 65 reported | 14.0% | 13.4% | 52% | Context only | |
| Gross marginHigher is better · 72 reported | 95.8% | 58.1% | 100% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around RPRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 11.26T JPY (≈$76.6B) | 99 | 72 | |
| 1 | 52.9B USD | 99 | 57 | |
| 3 | 8.24T JPY (≈$56.0B) | 98 | 75 | |
| 3 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 32 | 54.9B USD | 83 | 59 | |
| 33 | 73.2B SAR (≈$19.8B) | 82 | 56 | |
| 33 | 16.7B CHF (≈$19.2B) | 82 | 47 | |
| 35 | 6.17T JPY (≈$42.0B) | 81 | 70 | |
| 36 | 38.4B USD | 80 | 50 | |
| 36 | 48.9B USD | 80 | 54 | |
| 38 | 3.53T JPY (≈$24.0B) | 79 | 68 | |
| 38 | 63.0B USD | 79 | 65 | |
| 40 | 45.9B USD | 78 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score